Loading clinical trials...
Loading clinical trials...
Autologous Incubated Macrophages (ProCord) is being developed as a therapy for acute, complete spinal cord injury (SCI). The therapy is intended to reverse the loss of motor and sensory function. Fol...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Proneuron Biotechnologies
Collaborators
NCT07663266 · Multiple Sclerosis, Spinal Cord Injury
NCT07090473 · Acute Spinal Cord Injury (SCI), Acute Spinal Cord Injury of Traumatic Origin (tSCI)
NCT07213986 · Neurogenic Bowel Dysfunction, Spinal Cord Injury
NCT07550699 · Acquired Brain Injury (Including Stroke), Spinal Cord Injury, and more
NCT07234903 · Spinal Cord Injury, SCI, and more
Craig Hospital
Englewood, Colorado
Shepherd Center
Atlanta, Georgia
UMDNJ
Newark, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions